Medicare costs for neovascular age-related macular degeneration, 1994-2007.
about
The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular DegenerationAn Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology.Use of health care claims data to study patients with ophthalmologic conditionsA risk score for the prediction of advanced age-related macular degeneration: development and validation in 2 prospective cohorts.Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.Age-related macular degeneration: genetics and biology coming together.Diffusion of technologies for the care of older adults with exudative age-related macular degeneration.Calcium, ARMS2 genotype, and Chlamydia pneumoniae infection in early age-related macular degeneration: a multivariate analysis from the Nagahama study.The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study.Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade.Subretinal Pigment Epithelial Deposition of Drusen Components Including Hydroxyapatite in a Primary Cell Culture Model.Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents.Drug delivery techniques for treating age-related macular degeneration.Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.Visual processing in patients with age-related macular degeneration performing a face detection test.Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization.Lactation, female hormones and age-related macular degeneration: the Tromsø Study.Association of Rare Predicted Loss-of-Function Variants in Cellular Pathways with Sub-Phenotypes in Age-Related Macular Degeneration.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study
P2860
Q28645952-493C968F-D3CE-4CE6-A89C-7D295EAD13E3Q30489873-D6BAF951-C45F-4F76-BED8-4B4E067332F9Q30735544-EF098809-B5CC-4F31-B9BA-1BC04718EB9EQ33849399-7DA444A7-5EB8-4C48-BF13-BE725F8059E6Q34092454-384CBBD8-742E-44A6-8FB2-8A50ACD478F4Q34158108-C7184C8B-EC64-4DBA-9903-C89B528AD375Q34440797-478DBFA5-DA01-4FB4-A824-4CE75E787FE0Q34503375-2CDC0454-A1F9-4037-A438-844B54E5F797Q35198182-CDC0BEC3-4CB7-4214-BBD8-8A08BED1278BQ36140110-E2DB4FF7-46CC-4C24-BD79-CF9C021D248CQ37533189-CB046097-9960-4CE5-BA23-2C21B22433DDQ37629530-82D80680-2853-4BAF-8251-C0649E255624Q38062429-D76BF8EB-CDAC-4125-9DED-6FDFF31D0E2BQ38161953-4EB8DC7B-C6A5-4D41-BDC2-C9CF4E8F803EQ38867052-26F0C83F-E8A7-4C1D-B7FA-F71815754827Q40983763-1A39A75B-5F5A-4E41-8FF0-A6BDB61A8B95Q41936178-1FC0FEFD-5317-4D05-8B80-9E6551B87FF6Q44245376-C401E531-7B01-4DD6-8933-8F4AB9C81347Q47335501-5AB49977-71D7-4332-A172-1FB657E0BAB4Q47442388-A13A2CE5-6727-4C08-8E81-3DAB06D03266Q58384520-71FB9235-D5D3-49FD-8B03-505B97F5B536
P2860
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@ast
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@en
type
label
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@ast
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@en
prefLabel
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@ast
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@en
P2093
P2860
P1476
Medicare costs for neovascular age-related macular degeneration, 1994-2007.
@en
P2093
Frank A Sloan
Kofi Acquah
Paul P Lee
Prithvi Mruthyunjaya
Shelley Day
P2860
P304
P356
10.1016/J.AJO.2011.05.008
P407
P577
2011-08-16T00:00:00Z